Request for information

FTC and DOJ Seek Info on Serial Acquisitions, Roll-Up Strategies Across U.S. Economy

Retrieved on: 
화요일, 5월 28, 2024

Often, businesses do not have to report these deals to the federal antitrust agencies, allowing firms to amass significant control over key products, services, or labor markets without government scrutiny.

Key Points: 
  • Often, businesses do not have to report these deals to the federal antitrust agencies, allowing firms to amass significant control over key products, services, or labor markets without government scrutiny.
  • The agencies have proposed amending the premerger notification forms to require firms to disclose more information about each party’s prior acquisition history.
  • In addition, the FTC and DOJ’s 2023 Merger Guidelines recognize that serial acquisitions have the potential to violate the antitrust laws.
  • The FTC’s Section 5 policy statement also makes clear that serial mergers, acquisitions or joint ventures can be anticompetitive.

    The public will have 60 days to submit comments at Regulations.gov, no later than July 22, 2024.

Charlotte's Web Reports 2024 First Quarter Financial Results

Retrieved on: 
수요일, 5월 8, 2024

LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024.

Key Points: 
  • LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024.
  • Charlotte's Web has made steady progress on its previously disclosed 'True North' pillars and the Company will be providing updates quarterly.
  • Improved loyalty programs and promotions introduced during the first quarter have increased new subscriber growth by approximately 25% quarter over quarter, with retention rates above 90%.
  • New wellness products and formats are planned for 2024 following the successful Q1 launch of Charlotte's Web "Stay Asleep" Cannabinol (CBN) gummies.

LiTHOS Selected for Next Phase in ENAMI's Direct Lithium Extraction Initiative

Retrieved on: 
목요일, 4월 25, 2024

VANCOUVER, BC, April 25, 2024 /PRNewswire/ - LiTHOS Group Ltd., ("LiTHOS" or the "Company") (CBOE CA: LITS) (OTCQB: LITSF) (FSE: YU8) (WKN: A3ES4Q) a leader in sustainable lithium production technologies, is pleased to announce its selection for the next phase of the Chilean National Mining Company (ENAMI)'s direct lithium extraction project.

Key Points: 
  • VANCOUVER, BC, April 25, 2024 /PRNewswire/ - LiTHOS Group Ltd., ("LiTHOS" or the "Company") (CBOE CA: LITS) (OTCQB: LITSF) (FSE: YU8) (WKN: A3ES4Q) a leader in sustainable lithium production technologies, is pleased to announce its selection for the next phase of the Chilean National Mining Company (ENAMI)'s direct lithium extraction project.
  • This selection follows a competitive global Request for Information (RFI) where LiTHOS showcased the application of its innovative AcQUA™ extraction technology for the High Andean Salt Flats project in the Atacama Region.
  • The lab testing phase is crucial for assessing the feasibility and effectiveness of LiTHOS's AcQUA™ technology in promoting sustainable lithium extraction practices that can operate in harsh field environments.
  • LiTHOS Technology is honored to contribute to this significant project, which aligns with its strategic objectives and the global movement toward sustainable mining practices.

FTC, HHS Extend Public Comment Period on Generic Drug Shortages and Competition Request for Information

Retrieved on: 
화요일, 4월 2, 2024

The Federal Trade Commission and the U.S. Department of Health and Human Services (HHS) are extending the deadline for the public to comment on a joint Request for Information (RFI) that seeks to understand how the practices of group purchasing organizations (GPOs) and drug wholesalers may be contributing to generic drug shortages.

Key Points: 
  • The Federal Trade Commission and the U.S. Department of Health and Human Services (HHS) are extending the deadline for the public to comment on a joint Request for Information (RFI) that seeks to understand how the practices of group purchasing organizations (GPOs) and drug wholesalers may be contributing to generic drug shortages.
  • In the RFI, the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.
  • The comment period was originally set to end on April 15, 2024.
  • The Federal Trade Commission develops policy initiatives on issues that affect competition, consumers, and the U.S. economy.

FTC Issues Infant Formula Supply Disruptions Report

Retrieved on: 
화요일, 4월 2, 2024

Today, the Federal Trade Commission issued a report on market factors relevant to infant formula supply disruptions, which details aspects of the U.S. infant formula market that rendered it vulnerable to supply disruptions in 2022.

Key Points: 
  • Today, the Federal Trade Commission issued a report on market factors relevant to infant formula supply disruptions, which details aspects of the U.S. infant formula market that rendered it vulnerable to supply disruptions in 2022.
  • The report also outlines considerations for policymakers to help create a more resilient infant formula supply going forward.
  • The Commission’s report follows a Request for Information launched in 2022 which solicited comments from members of the public, industry, trade groups, and academics on a variety of issues related to the disruptions and the infant formula market more broadly.
  • These comments informed the FTC’s analysis as the Commission considered whether certain features of the infant formula market contributed to the industry-wide disruptions in 2022, and how competition-based reforms may promote greater resiliency.

FTC, HHS Extend Public Comment Period on Generic Drug Shortages and Competition Request for Information

Retrieved on: 
화요일, 4월 2, 2024

The Federal Trade Commission and the U.S. Department of Health and Human Services (HHS) are extending the deadline for the public to comment on a joint Request for Information (RFI) that seeks to understand how the practices of group purchasing organizations (GPOs) and drug wholesalers may be contributing to generic drug shortages.

Key Points: 
  • The Federal Trade Commission and the U.S. Department of Health and Human Services (HHS) are extending the deadline for the public to comment on a joint Request for Information (RFI) that seeks to understand how the practices of group purchasing organizations (GPOs) and drug wholesalers may be contributing to generic drug shortages.
  • In the RFI, the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.
  • The comment period was originally set to end on April 15, 2024.
  • The Federal Trade Commission develops policy initiatives on issues that affect competition, consumers, and the U.S. economy.

Aeros Launches Site Selection For Airship Assembly Facility

Retrieved on: 
토요일, 3월 9, 2024

LOS ANGELES, March 9, 2024 /PRNewswire-PRWeb/ -- Aeros, a leading innovator in the airship manufacturing industry, is officially initiating the site selection process for its new state-of-the-art airship manufacturing and assembly facility. The company is issuing a Request for Information to identify potential locations capable of supporting the advanced infrastructure required for the production of its zero-emission electric variable buoyancy cargo airships (eVBA).

Key Points: 
  • Aeros, a leading innovator in the airship manufacturing industry, is officially initiating the site selection process for its new zero-emission cargo airship manufacturing and assembly facility.
  • LOS ANGELES, March 9, 2024 /PRNewswire-PRWeb/ -- Aeros, a leading innovator in the airship manufacturing industry, is officially initiating the site selection process for its new state-of-the-art airship manufacturing and assembly facility.
  • Strategic Site Selection: Aeros is seeking partnerships with states and communities capable of hosting the facility, with the potential for expansion up to 200 acres.
  • Job Creation and Economic Impact: The establishment of the facility is expected to generate thousands of high-paying jobs in the cleantech aviation and aerospace manufacturing sector.

Nous Infosystems Recognized as a Major Contender in Everest Group Application Transformation Services PEAK Matrix® Assessment 2024 - North America

Retrieved on: 
화요일, 2월 20, 2024

EDISON, N.J., Feb. 20, 2024 /PRNewswire/ -- Nous Infosystems , a leading global IT solutions provider delivering innovative technology services and solutions, announced its recognition as a Major Contender in Application Transformation Services PEAK Matrix® Assessment 2024 - North America by Everest Group.

Key Points: 
  • EDISON, N.J., Feb. 20, 2024 /PRNewswire/ -- Nous Infosystems , a leading global IT solutions provider delivering innovative technology services and solutions, announced its recognition as a Major Contender in Application Transformation Services PEAK Matrix® Assessment 2024 - North America by Everest Group.
  • The Everest Application Transformation Services Peak Matrix Assessment, a thorough analysis assessing 28 application transformation service providers, provides valuable insights into the dynamics of the North American landscape.
  • Anurag Chauhan, CEO, Nous Infosystems, expresses, "Being recognized as a Major Contender in Application Transformation Services solidifies our dedication to delivering business-centric solutions.
  • Sreenivasan Narayanan, EVP - Microsoft Global Alliances at Nous Infosystems, adds, "Attaining Major Contender status in Application Transformation Services highlights our operational and technical expertise.

Nous Infosystems Recognized as a Major Contender in Everest Group Application Transformation Services PEAK Matrix® Assessment 2024 - North America

Retrieved on: 
화요일, 2월 20, 2024

EDISON, N.J., Feb. 20, 2024 /PRNewswire/ -- Nous Infosystems , a leading global IT solutions provider delivering innovative technology services and solutions, announced its recognition as a Major Contender in Application Transformation Services PEAK Matrix® Assessment 2024 - North America by Everest Group.

Key Points: 
  • EDISON, N.J., Feb. 20, 2024 /PRNewswire/ -- Nous Infosystems , a leading global IT solutions provider delivering innovative technology services and solutions, announced its recognition as a Major Contender in Application Transformation Services PEAK Matrix® Assessment 2024 - North America by Everest Group.
  • The Everest Application Transformation Services Peak Matrix Assessment, a thorough analysis assessing 28 application transformation service providers, provides valuable insights into the dynamics of the North American landscape.
  • Anurag Chauhan, CEO, Nous Infosystems, expresses, "Being recognized as a Major Contender in Application Transformation Services solidifies our dedication to delivering business-centric solutions.
  • Sreenivasan Narayanan, EVP - Microsoft Global Alliances at Nous Infosystems, adds, "Attaining Major Contender status in Application Transformation Services highlights our operational and technical expertise.

FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen

Retrieved on: 
수요일, 2월 14, 2024

In the Request for Information (RFI), the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.

Key Points: 
  • In the Request for Information (RFI), the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.
  • The joint RFI is asking these questions to help uncover the root causes and potential solutions to drug shortages.
  • “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen.
  • - Whether and to what extent concentration among GPOs and drug wholesalers has disincentivized suppliers from competing in generic drug markets.